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Abstract
Background: Although rapid diagnostic tests (RDTs) for Plasmodium falciparum infection that target histidine rich protein 2
(PfHRP2) are generally sensitive, their performance has been reported to be variable. One possible explanation for variable
test performance is differences in expression level of PfHRP in different parasite isolates.
Methods: Total RNA and protein were extracted from synchronised cultures of 7 P. falciparum lines over 5 time points of the
life cycle, and from synchronised ring stages of 10 falciparum lines. Using quantitative real-time polymerase chain reaction,
Western blot analysis and ELISA we investigated variations in the transcription and protein levels of pfhrp2, pfhrp3 and
PfHRP respectively in the different parasite lines, over the parasite intraerythrocytic life cycle.
Results: Transcription of pfhrp2 and pfhrp3 in different parasite lines over the parasite life cycle was observed to vary
relative to the control parasite K1. In some parasite lines very low transcription of these genes was observed. The peak
transcription was observed in ring-stage parasites. Pfhrp2 transcription was observed to be consistently higher than pfhrp3
transcription within parasite lines. The intraerythrocytic lifecycle stage at which the peak level of protein was present varied
across strains. Total protein levels were more constant relative to total mRNA transcription, however a maximum 24 fold
difference in expression at ring-stage parasites relative to the K1 strain was observed.
Conclusions: The levels of transcription of pfhrp2 and pfhrp3, and protein expression of PfHRP varied between different P.
falciparum strains. This variation may impact on the detection sensitivity of PfHRP2-detecting RDTs.
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Introduction
The ability to accurately diagnose malaria infections is critical to
the control and elimination of this disease [1]. This is of particular
importance in settings where laboratory facilities are poorly
resourced. Rapid diagnostic tests (RDTs) for malaria have the
potential to significantly improve malaria diagnosis and to
contribute to reduction in morbidity and mortality in endemic
countries, particularly in remote areas. When deployed in
conjunction with artemisinin-combination therapy and insecti-
cide-treated bednets, they form a cornerstone of current efforts to
eliminate malaria [2].
Many of the RDTs marketed to diagnose malaria target
Plasmodium falciparum histidine-rich protein 2 (PfHRP2) that
circulates in the bloodstream of the patient [3]. PfHRP3, another
protein generated by the parasite, may also be detected by
PfHRP2-detecting RDTs [4]. While PfHRP2-detecting RDTs
generally show good sensitivity and specificity, there are also
many reported disparities in their performance, with no apparent
pattern of geographic or quality-related causative factors [5].
Although most reported sensitivity variations were observed as
false negative tests at relatively low parasitemia (, 250 parasites
per microlitre, P/mL), in some studies RDTs have been reported
to yield false negative results at relatively high parasitemia (.
1000 P/mL) [6].
Several factors may contribute to the variable sensitivity
reported for PfHRP2-detecting RDTs. These include genetic
variation of PfHRP2 between parasites. We have previously shown
that while genetic polymorphism in PfHRP2 is extensive, it does
not appear to affect RDT detection sensitivity at levels . 200 P/
uL [7]. Another potential factor may be variation in the levels of
PfHRP2 and PfHRP3 proteins produced by different parasite
strains, likely a consequence of variations in mRNA transcription
levels.
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PfHRP2 is a 60-105 kDa water-soluble protein specific to P.
falciparum. It is encoded by pfhrp2, a subtelomeric gene located on
chromosome 7 [8,9,10,11]. Studies of gene expression across the
parasite lifecycle indicate that PfHRP2 protein synthesis begins
with immature parasites (rings), two hours after invasion of the red
blood cell [9]. Transcription and translation continues throughout
the rest of the blood stage lifecycle in asexual parasites and in the
developing gametocytes [8,11,12,13]. The protein is found on the
surface of infected erythrocytes, within the parasite cytosol and in
the peripheral blood of infected individuals [14]. The protein has
multiple copies of very similar alanine and histidine-rich repeats
[8] that serve as suitable epitopes for recognition by antibodies
present in purpose-designed antigen-capture immunochromato-
graphic tests, commonly referred to as Rapid Diagnostic Tests
(RDTs). PfHRP3 is very similar to PfHRP2, with related alanine-
histidine rich repeats and the same secretory signal. The histidine
content ranges from approximately 28% in PfHRP3 to 34% in
PfHRP2 [8].
The parasite expresses most of its genes as it invades and
develops within the erythrocyte, with at least 60% of the genome
transcriptionally active during the intraerythrocytic asexual cycle
[15]. A number of housekeeping genes [16,17,18,19,20] including
seryl tRNA synthase (s-tRNA syn or tRNA) and MAL13P1.209 60S
ribosomal subunit protein L18 (mal13), are transcribed at a
relatively constant rate across the asexual lifecycle of the 3D7
falciparum strain [15,21,22]. The relative abundance of many
other mRNAs varies at different stages in the life cycle
[15,23,24,25,26]. Overall mRNA levels vary significantly between
different lifecycle stages and exhibit a moderately positive
correlation with protein abundance [15,23]. Groups of function-
ally related genes share common expression profiles [15].
A plausible hypothesis is that the amount of PfHRP produced
by the parasite varies between different isolates, and as a
consequence different amounts of this target protein would be
available for detection by RDTs. PfHPR2 production and release
has been characterised in a limited number of strains during the
intraerythrocytic life cycle [8,9,11,12,27,28]. However there is a
paucity of data available on levels of intraerythrocytic transcription
of pfhrp2 and pfhrp3 across the asexual cycle [29] and no detailed
study has been undertaken on the variability of transcription and
abundance of PfHRP across the asexual life cycle, and also
between different parasite lines.
In this paper, we report the pattern of transcription of pfhrp2 and
pfhrp3, and of abundance of PfHRP protein, in different parasite
strains, at several time points over the blood stage life cycle.
Further, the potential impact that the variation in protein
expression has on RDT detection sensitivity is investigated.
Defining reasons for RDT failure is of significant public health
importance and will contribute to improving diagnostics for
falciparum malaria.
Methods
Sample material
Cryopreserved parasites originating from varied geographic
areas (Table 1) were cultured in vitro [30] and synchronised
repeatedly using 5% sorbitol solution [31] and once with the
MACSH Separation Column (Miltenyi Biotec USA) [32]. Seven
lines were used to study the transcription dynamics of pfhrp2 and
pfhrp3 through the erythrocytic life cycle (Table 1), where
synchronised parasites (ring stage, approximately 5% parasitemia
in 100 mL volume) were gently and thoroughly mixed and split
into 10 equal aliquots of 10 mL each. Two aliquots were harvested
immediately (time point 1), one flask for RNA isolation and
another flask for protein isolation. The remaining aliquots were
returned to culture and incubated at 37uC, then harvested in pairs
at 12-hourly intervals (time points 2–5), to enable sampling at
different stages of development over the intraerythrocytic life
cycle. A further 10 parasite lines (Table 1) were used to compare
the transcription levels of pfhrp2 and pfhrp3 at predominantly ring
stage, the stage seen in patient blood. For RNA isolation,
parasitized erythrocytes were pelleted, lysed using saponin
(0.075%) in RNase-free tubes then frozen at 280uC. For protein
isolation, culture supernatant was removed and red cell pellets
were frozen at 280uC until protein extraction.
Confirmation of lifecycle stage
For each sample, the number and proportion of ring-stage
parasites was determined by microscopically counting 500 infected
erythrocytes. No gametocytes were observed in these cultures.
RNA isolation
Total RNA was isolated from each parasite pellet using the
NucleoSpinH RNA II Kit (Macherey-Nagel Germany), following
the manufacturer’s instructions. A second elution step was added
to maximise yield as previously described [33]. All samples were
treated with DNase, eluted in 60 mL RNase-free water; the eluted
RNA was stored at 280uC.
Real-time quantitative RT-PCR
Total RNA was reverse-transcribed into cDNA using Super-
ScriptTM III Reverse Transcriptase (Invitrogen USA) and random
hexamers. The real-time PCR primers were designed based on a
pfhrp2 fragment alignment of P. falciparum 3D7 (GenBank accession
number BM275665), FCBR (GenBank accession X69922) and
ITG2 (GenBank accession U69551). The forward primers for both
pfhrp2 and pfhrp3 were designed to span both exon 1 and part of
exon 2, with the reverse primer binding in exon 2. Primers for
pfhrp3 were designed using an alignment of ITG2 (GenBank
accession U69552) and FCC1/HN (GenBank accession
AF202093). Primer sequences are shown in Table 2.
Real-time PCR conditions for pfhrp2 and pfhrp3 were optimised
using P. falciparum 3D7 cDNA. The use of 150 nM primers per
reaction and a 15 minute enzyme activation period on the
MX4000 (Stratagene USA) gave the best reproducibility, and were
used in all real-time PCR experiments for this study. Two
housekeeping genes, PF07_0073 seryl tRNA synthase (s-tRNA syn
or trna) gene and MAL13P1.209 (mal13), the 60S ribosomal
subunit protein L18 were used as endogenous control transcripts
to normalize mRNA levels [34].
All samples were run in triplicate using the ABsolute QPCR
SYBR Green Mix (ABGene United Kingdom) according to the
manufacturer’s instructions. The following cycling conditions were
used: 15 minutes at 95uC for initial denaturation and enzyme
activation, followed by 40 cycles of 95uC for 30 seconds, 57uC for
40 seconds, and 72uC for 40 seconds, followed by a final extension
of 57uC for 1 minute. The dissociation curve for pfhrp2 gave a
melting temperature at 76.7uC while for pfhrp3 it was 77.8uC.
Experiments where non-specific peaks in relation to the dissoci-
ation curves were observed were repeated. The mean Ct was
determined and used in the DCt method [35] to calculate the
amount of pfhrp2 and pfhrp3 relative to s-tRNA syn and mal13.
Protein extractions
Pelleted infected red blood cells were thawed and resuspended
in 1% Triton X-100 diluted with phosphate-buffered saline (PBS)
and 1/1000 volume of a cocktail of proteinase inhibitors (Thermo
P. falciparum Histidine-Rich Protein Expression
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Scientific USA). Samples were then frozen (280uC) and thawed
three times, with vortexing every 15 minutes. After protein
solubilization the solution was spun at 15 000 rpm for 30 minutes
at 4uC and the supernatant removed for use in protein
experiments.
Western blot analysis
A 40 mL supernatant aliquot was diluted 1:5 with PBS-T (PBS-
Tween 20, 0.05%) to reduce interference from residual hemoglo-
bin. One third volume of 36SDS sample loading buffer was added
to the extracts, and boiled for 10 minutes prior to loading on an
SDS-page gel (NuPage 10% Bis-Tris Gel, Invitrogen USA), run
for 1 hour at 60 V then 1.5 hour at 150 V. Proteins were then
transferred from the SDS-page gel to a 0.45 mm PVDF membrane
(Invitrogen USA) at 100 V for 1.5 hours. Following transfer, the
membrane was blocked overnight in 5% skim milk powder
dissolved in 100mL PBS-T. The membrane was then incubated
with the primary antibody, PTL3 (kindly provided by Dr Martin
Bubb, National Bioproducts Institute, South Africa) at 1:5000
dilution. Following washing in PBS-T, the membrane was
incubated with an anti-mouse polyvalent immunoglobulin-alkaline
phosphatase conjugate (Sigma USA) at 1:5000 dilution. The signal
was detected by CDP Star chemiluminescent substrate (Roche
Germany) and exposed to imaging films.
Enzyme-Linked Immunosorbent Assay
A PfHRP2 quantitative antigen-capture ELISA (Bioline SD
Malaria Antigen Pf, Standard Diagnostics Korea) was used
according to the manufacturer’s instructions. Positive and negative
control wells were included to quantitate protein levels for all
samples. 3D7 culture supernatant containing a known concentra-
tion of PfHRP2 was used for standard curve construction. All
samples were tested as undiluted, 1/100, 1/200 and 1/300
dilutions and run in duplicate. Absorbance was measured at
450 nm and 650 nm using a microplate spectrophotometer
(SpectraMax Molecular Devices USA).
The software package SoftMax Pro software (Molecular Devices
USA) was employed to quantify the protein levels in ng/mL.
Samples whose concentration fell outside the standard curve were
further diluted and the test repeated. Calculated PfHRP2 levels
were then normalised against the samples own trna transcription
Table 1. Origin of parasite strains used in transcription of pfhrp2 and pfhrp3 and expression of PfHRP.
Isolate Origin Samples assayed Remarks
Hb3 Honduras Groups 1, 2, 4, 5 pfhrp3 negative control
Dd2 Thailand Groups 1, 4, 5 pfhrp2 negative control
D6 Africa Groups 1*, 2, 4, 5
K1 Thailand Groups 1, 3, 4, 5 Identical pfhrp2 sequence-GA3.
W2 Thailand Groups 1, 3, 4
PH1 Philippines Groups 1, 4, 5 Identical pfhrp2 sequence- PH3.
S55 Solomon Islands Groups 1, 2, 3, 4
N70 Solomon Islands Group 1 Identical pfhrp2 sequence-SJ44.
FCQ33 Papua New Guinea Group 1 Identical pfhrp2 sequence-FCQ41.
FCQ41 Papua New Guinea Group 1 Identical pfhrp2 sequence-FCQ33.
PH3 Philippines Group 1 Identical pfhrp2 sequence-PH1.
SJ44 Solomon Islands Group 1 Identical pfhrp2 sequence- N70.
GA3 Thailand Group 1 Identical pfhrp2 sequence-K1.
MCK Malaysia Group 1
AN101 Papua New Guinea Group 1
FCR3 Africa Group 1
7G8 South America Group 1
*Assayed for protein level only.
doi:10.1371/journal.pone.0022593.t001
Table 2. Primer sequences and real time PCR conditions used
to quantify the transcription levels for pfhrp2 and pfhrp3 with
reference housekeeping genes 3D7 P. falciparum gene family
s-tRNA and 60S ribosomal subunit protein L18.
PCR conditions Primer name Sequence
95uC 15 mins, 1 cycle Forward
40 cycles 95uC 30 sec, hrp2 rna 1 TGTTAGATAACAATAATTCCGC
57uC 40 sec, 72uC 40 sec Reverse
hrp2 exon 2 R1 AGCATGATGGGCATCATCTA
95uC 15 mins, 1 cycle Forward
40 cycles 95uC 30 sec, hrp3 rna 1 TGTTAGATAACAATAACTCCGA
57uC 40 sec, 72uC 40 sec Reverse
hrp3 exon 2 R1 TGCATGATGGGCATCACCTG
95uC 15 mins, 1 cycle Forward
40 cycles 95uC 30 sec, s-tRNA syn F AAGTAGCAGGTCATCGTGGTT
57uC 40 sec, 72uC 40 sec Reverse
s-tRNA syn R TTCGGCACATTCTTCCATAA
95uC 15 mins, 1 cycle Forward
40 cycles 95uC 30 sec, 60S ribo L18 F ATTATCACATGGCCAATCACC
57uC 40 sec, 72uC 40 sec Reverse
60S ribo L18 R CAATCTCTTATCATCTGTTATT
doi:10.1371/journal.pone.0022593.t002
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value to account for potential differences in the number of
parasites in the sample. The trna values from the transcript dataset
for the K1 parasite were then used for this normalis-
ation: normalised PfHRP2sample parasite = PfHRP2sample parasite6
(trnasample parasite/trnaK1).
Rapid Diagnostic Tests
To investigate whether differences in PfHRP protein level
results in a difference in the detection limit on RDTs, the ring-
stage protein sample (80–100% ring) from parasite strains K1, D6
and Hb3 were tested without dilution, then at 1/100, 1/200, and
1/300 dilutions in 16PBS, on three RDTs (ICT Malaria, ICT
Diagnostics South Africa; First Response Malaria Antigen
Combination Test, Premier Medical Corporation India; SD
Malaria Rapid Test, Standard Diagnostics Korea).
The experiment was then repeated using the same number of
intact parasitized red blood cells of the three parasite lines at seven
doubling dilutions (15 000 P/mL serially diluted down to 10 P/mL)
at 50% hematocrit. The RDTs were read using the WHO Colour
Intensity chart for RDTs with a scale of 0-4, based on the intensity
of the band colour, 4 being the strongest band colour, 3 moderate
colour, 2 weak colour, 1 faint colour, and 0 negative (Dr D. Bell,
WPRO-WHO, 2004, unpublished).
Statistical analysis
Spearman Rank Correlation using GraphPad PRISM software
(GraphPad Software, La Jolla USA) was applied to assess the
relationship between transcript and parasite stage, protein and
parasite stage, and the relationship between transcription and
expression.
Results
Grouping parasites by developmental stages
Preliminary experiments indicated that the different strains of P.
falciparum to be characterised in this work have different asexual
replication times. To compare levels of transcription of pfhrp2 and
pfhrp3 at the well-recognized asexual stages, we grouped parasites
based on the proportion that were ring-stage at different times
across the lifecycle. For 5 of the 7 lines studied (HB3, Dd2, W2,
K1 and PH1, Table 1) the parasites present at time points 1, 2 and
5 were predominantly rings, trophozoites at time point 3, and
schizonts at time point 4. Parasites returned to ring stages at time
point 5 corresponding with the start of a new cycle. In contrast, the
lifecycle of the D6 and S55 parasite lines was shorter, with
parasites being predominantly rings by time point 4. This indicates
that different parasite strains have different asexual replication
times. To reflect transcriptional changes for pfhrp2 and pfhrp3 at
different asexual stages, we grouped parasites based on the
proportion of parasites that were ring-stage: Group 1, 80–100%,
Group 2, 60–79%, Group 3, 40–59%, Group 4, 20–39% and
Group 5, 0–19%. After grouping, some parasite lines have samples
representing 4 groups and some have samples representing only 3
groups (Table 1). This is because of differences in the age of rings
at the time when experiment started and differences in the growth
rate of different lines.
Transcription of pfhrp2 and pfhrp3 peaks at ring stage
Using quantitative real-time PCR, transcription of both pfhrp2
and pfhrp3 was observed to peak at ring stage (Figure 1A and 1B). It
should be noted that transcription level of pfhrp2 was not determined
for Dd2 because it lacks the pfhrp2 gene, and that transcription levels
of pfhrp2 and pfhrp3 were not determined for the group 1 sample of
D6 because the RNA was degraded (D6 had a Group 1 protein
sample but no Group 1 mRNA sample). A significant positive
correlation was observed between the proportion of rings and the
level of transcription for both pfhrp2 and pfhrp3 (P, 0.01) (Figure 1A
and 1B). This was a consistent finding irrespective of whether the
transcription levels of pfhrp2 and pfhrp3 were normalised against trna
(Figure 1A and 1B) or against mal13 (Figure S1A and S1B).
Transcription of pfhrp2 and pfhrp3 varies between
parasite strains at different lifecycle stages
The level of transcription of pfhrp2 and pfhrp3 relative to the K1
control parasite strain varied over the course of the intraerythro-
cytic life cycle in all strains studied (Figure 2A and 2B). Levels were
also observed to vary between strains. However, the rank order of
the levels of transcription between strains varied at different time
points. For example, S55 strain ranked the highest in quantity of
pfhrp2 transcript when the proportion of rings was between 40 to
100%, but ranked lower when the proportion of rings fell below
40%.
Transcription of pfhrp2 is higher than pfhrp3
Levels of transcription of pfhrp2 were consistently higher than for
pfhrp3 in all parasite lines and at all time points tested. This finding
was true irrespective of the housekeeping gene used to normalise
the data. Figure 3 shows the data normalised to trna gene.
Levels of transcription of pfhrp2 vary between strains at
ring stage
Levels of pfhrp2 transcripts at 80–100% ring stage were
compared for 15 strains against K1 (Figure 4). The ratio of
transcription levels relative to K1 control parasite varied from a
minimum ratio of 0.15 (Hb3) to a maximum of 1.9 (MCK). The
experiment including synchronisation, culture and quantification
of transcripts was repeated for 5 parasite lines at ring stages. The
differences in transcription measurements of the two experiments
were , 5.3%. As the sequence of the pfhrp2 gene varies
significantly between strains [7], a separate analysis of transcrip-
tion levels for parasite strains with the same pfhrp2 sequence was
undertaken. Of interest, differences in transcription were marked
between some paired strains: PH1 and PH3 (1.4 vs 0.4), K1 and
GA3 (1.0 vs 0.3), and moderate between SJ44 and N70 (1.1 vs
0.9), FCQ33 and FCQ41 (0.5 vs 0.3).
Transcription of pfhrp2 and pfhrp3 is reduced when one
of the genes is absent
Pfhrp3 is absent in the P. falciparum laboratory clone Hb3 [36].
Of interest, we observed that the level of transcription of pfhrp2 in
this parasite line was lower compared to all other strains tested. In
other words, no compensatory increase in pfhrp2 transcription was
observed when pfhrp3 was absent. Similarly, the parasite line Dd2
lacks pfhrp2 [37]. We likewise observed that transcription of pfhrp3
in this line was the lowest of those tested with no compensatory
increase to account for the lack of pfhrp2.
Levels of histidine-rich proteins
Monoclonal antibodies raised against PfHRP2 have been shown
to cross-react with PfHRP3 [8]. Thus, although our experiments
were designed to measure the level of PfHRP2 protein, it should
be noted that PfHRP3 was also likely to contribute to the result. As
no PfHRP3 specific antibody ELISA was available, we were
unable to investigate the relative contribution of PfHRP2 and
PfHRP3 in the PfHRP quantitative ELISA.
Western blot analysis confirmed the presence of PfHRP2 at
all time points examined across the asexual life cycle (Figure S2).
P. falciparum Histidine-Rich Protein Expression
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When levels of PfHRP protein were measured by ELISA over
the intraerythrocytic life cycle, results demonstrate that the
protein levels were relatively constant throughout the erythro-
cytic cycle compared to transcription levels in 5 lines tested
(Figure 5A). When levels in 16 strains were measured at 80–
100% ring stage, there was a considerable difference in protein
expression between strains with a maximum of 24 fold (1.20 in
S55 vs. 0.05 in FCQ41) difference in PfHRP levels (Figure 5B).
When levels of PfHRP in parasite strains with identical pfhrp2
sequence were compared at predominant ring stage (Group 1), a
1–4 fold difference in protein levels was observed between the
paired strains (Figure 5B). Three parasite lines were cultured,
synchronised and harvested again to repeat the experiment.
Measured levels of protein expression between the two
experiments differed by a maximum of 22% for the 3 parasite
lines tested.
In contrast to transcription, protein levels did not appear to be
related to the number of ring stage parasites (P . 0.05, Figure S3).
The intraerythrocytic lifecycle stage at which the highest level of
protein was present varied across strains (Figure 5A). Expression of
PfHRP was observed to vary in different stages relative to the K1
control parasite (Figure 5C).
Figure 1. Transcription of pfhrp2 (A) and pfhrp3(B) normalised to trna over the intraerythrocytic life cycle of parasites (with varying
proportions of ring stage).
doi:10.1371/journal.pone.0022593.g001
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Correlation between transcription level of pfhrp2 and
abundance of PfHRP
No significant correlation was observed between abundance of
pfhrp2 transcripts and the level of PfHRP protein (P . 0.05,
Figure 5D). For a sample size of five isolates where both
transcription and protein abundance across the intraerythrocytic
life cycle were determined, our data were not conclusive. A larger
sample size may provide a better statistical analysis for examining
the relationship between transcription and expression for this gene
and protein.
Figure 2. Quantity of pfhrp2 (A) and pfhrp3 (B) transcripts in 5 P. falciparum lines over the intraerythrocytic life cycle (with varying
proportion of ring stage) relative to K1.
doi:10.1371/journal.pone.0022593.g002
P. falciparum Histidine-Rich Protein Expression
PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e22593
Higher protein levels result in a lower detection limit on
RDTs
The K1 and D6 parasite lines had a higher level of PfHRP
protein at ring-stage than the Hb3 parasite line. These three
parasite lines were used to test the sensitivity of three brands
of malaria RDTs. When the parasite protein extracts were
tested with the RDTs, K1 and D6 showed good detection
sensitivity down to the maximum dilution of 1/300, while
Hb3 tested negative when diluted below 1/100. The results
confirm that samples with higher protein levels test positive in
RDTs at higher dilutions than those with lower levels of
protein.
The experiment was repeated using an identical number of
parasitized blood cells of the cultured lines. D6 returned strong
positive results at all seven dilutions tested at 15 000 P/mL serially
diluted down to 10 P/mL, with an intensity score of 4 based on the
WHO RDT Colour Intensity Chart (Dr D. Bell, Western Pacific
Regional Office of the World Health Organization, WPRO-
WHO, 2004, unpublished). K1 returned strong positive results of 4
for all dilutions except the final dilution where the band intensity
was slightly weaker at a score of 3. Hb3 worked only weakly until
the second dilution, 10 000 P/mL with a score of 2.
Discussion
The purpose of this study was to investigate whether the
transcription of the pfhrp2 and pfhrp3 genes, and the levels of the
corresponding protein PfHRP, vary between different parasite
strains, and whether these variations influence the detection sensitivity
of malaria RDTs. Our data indicate that pfhrp2 and pfhrp3
transcription is highest at the ring stage of the intraerythrocytic life
cycle, a finding that agrees with the transcription profiles for these
genes using microarray analysis for the 3D7 strain which is available
in the PlasmoDB database [29]. In this study we have shown that
transcription levels of pfhrp2 vary widely between geographically
variant strains of the parasite, even for strains with the same pfhrp2
sequence and also between strains with different pfhrp2 sequence.
Control of transcription is believed to be under the influence of
various regulatory systems, many of which are incompletely
understood in Plasmodia [24,38].
It is clear that transcription patterns vary between genetically
distinct parasites [39]. The 59 untranslated region of genes (UTR)
may contain regulatory elements that interact with promoter
region elements to regulate transcription, or influence mRNA
stability or survival. The 39 UTR may also have an important role
Figure 3. Quantity of pfhrp2 transcription relative to pfhrp3 transcription in 5 parasite strains at varying proportion of ring stage.
doi:10.1371/journal.pone.0022593.g003
Figure 4. Quantity of pfhrp2 transcripts (relative to K1) in samples with 80–100% ring stage for 15 P. falciparum lines.
doi:10.1371/journal.pone.0022593.g004
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in regulation of gene function [40]. Although not investigated in
this study, different parasite lines with different pfhrp2, or even
identical coding sequences may differ in their 59 UTR and 39
UTR sequences, resulting in different levels of transcription.
Epigenetic mechanisms may also significantly affect transcrip-
tion [41]. Changes in chromatin structure may profoundly
influence the relationship between promoter and transcription
factors [38]. Nucleosome-free regions found at transcription start
Figure 5. Expression of PfHRPs in different P. falciparum lines over the intraerythrocytic life cycle. (A) Quantity of HRP protein expression in
parasites with varying proportion of ring stage of 5 P. falciparum lines. (B) Protein expression values relative to K1 for PfHRP in samples with 80–100%
ring stage for 15 P. falciparum lines. (C) Quantity of HRP protein expression in parasites with varying proportion of ring stage for 5 P. falciparum lines
normalised to K1. (D) Comparison of total pfhrp2 transcription and total expression of PfHRP across the intraerythrocytic life cycle for 5 parasite lines.
doi:10.1371/journal.pone.0022593.g005
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sites and core promoters are strongly associated with high levels of
gene expression in intraerythrocytic stages [42]. It is therefore
possible that epigenetic factors play a role in pfhrp2 and pfhrp3
transcription.
It should be noted that the levels of pfhrp2 and pfhrp3 transcripts
and PfHRP protein measured in this study constitute the amounts
of transcript or protein present at that timepoint, reflecting the
combined result of transcription and degradation of the target. For
transcripts, post-transcriptional control mechanisms including
mRNA stability and decay may contribute significantly to the
variation in the amount of transcripts present [43]. mRNA
translation efficiency can also be influenced by a range of factors.
Histone 396–494 of pfhrp3 may play a role in mRNA stability [44].
Variation in binding factor sequences in the 59 and 39 UTR may
also exert a significant influence on mRNA stability and
translation. Likewise, changes to the transcription start site may
regulate the translation efficiency of a given gene [40].
In all strains tested in this study, we observed that the level of
pfhrp2 transcripts was always higher than that of pfhrp3. This could
be a consequence of the promoter for pfhrp2 being stronger, or as a
result of a slower decay of pfhrp2 transcripts. A 59 flanking region of
pfhrp3 has been extensively used in transfection studies as a
promoter for reporter gene expression, paired with a 39 flanking
region of pfhrp2 as a terminator sequence [45,46]. However, there
is no report of using the pfhrp2 promoter for transfection, thus
precluding a comparison of the two promoters. In an earlier study,
levels of PfHRP2 to PfHRP3 were compared using immuno-
chemical methods, with results indicating that PfHRP3 protein
levels were lower than PfHRP2 [8].
The pfhrp2 and pfhrp3 genes are structurally very similar, with
regions flanking the tandem repeats, including untranslated regions,
showing up to 90% homology [8,10]. Both genes share many motifs
and the same secretory leader. Exon 2 of both pfhrp2 and pfhrp3
genes encode the histidine-rich amino acid repeats beginning 75–90
nucleotides downstream from the start [13]. Given the similarity of
the two genes, it is plausible that their gene products perform similar
functions, and that their transcription may be controlled by a
common regulatory mechanism. However, we observed that pfhrp2
transcription was lower when pfhrp3 was absent and vice versa. If the
products of these two genes have a similar function, it would be
expected that one would compensate for the absence of the other.
From our data, it may be suggested that these genes have a non-
overlapping function. pfhrp2 and pfhrp3 are not linked, occurring as
single copy genes on separate chromosomes [36]. Parasites lacking
either one gene or both genes have been reported in both laboratory
lines [47] and in clinical isolates in South America [48], suggesting
these genes are not essential for the survival and transmission of the
parasite in the human host.
The variation in transcription we observed was also reflected by
differences in the protein expression levels. Although PfHRP
protein expression was more constant throughout the intraeryth-
rocytic life cycle in 5 lines tested, wide variations in the level of
protein were observed between 16 strains at ring stage, the stage
circulating in patient blood, with up to a 24 fold difference
observed between strains. The results are in agreement with RDT
results observed using patient samples at 200 P/mL recently
reported from Colombia [49].
Importantly, we have shown that parasite strains with higher
protein levels have a lower detection limit on commercial RDTs
compared to those with lower protein levels. The same phenomenon
was observed when the number of parasites was controlled. Although
the quantity of HRPs in D6 was less than that in K1, RDTs used to
test these lines were strongly positive. When compared to the Hb3
result, which had a low protein level and was not detected at low
concentrations, a threshold is observed, below which the level of
protein affects RDT sensitivity. Parasites with low levels of protein will
be difficult to detect at low parasitemia (#200 P/mL). This provides
further evidence that the level of PfHRP protein is a major
determinant of the detection sensitivity of RDTs, and therefore that
such variations in protein abundance could contribute to variation in
the performance of PfHRP2- detecting RDTs. This consideration is
particularly important for testing of patients at low parasitemia,
where parasites with lower protein levels may return negative results
on malaria RDTs. Likewise, low parasite protein expression may also
explain why some RDTs return a negative result at relatively high
(.1 000 P/mL) parasitemia levels. An increased understanding of the
factors influencing RDT performance will likely help to improve the
performance and use of such malaria RDTs that are of significant
public health importance.
It should be pointed out that the parasite lines used in this study
have all been adapted to in vitro culture conditions. Although neither
pfhrp2 nor pfhrp3 genes were deleted during culture adaptation, it is
unknown whether levels of transcription of these genes, and
expression levels of the encoded proteins were affected during the
adaptation. Further work using these methods to quantify
transcription and expression on additional parasite isolates, and
especially testing of field isolates, to determine the extent of
variation, and the proportion of parasite isolates that produce low
level HRPs would strengthen this observation. The impact of
variation in protein level on RDT detection sensitivity in patients
also requires further study. Important experimental constraints
impede the measurement of PfHRP in field samples. These include
the lack of synchrony and inability to control parasitemia levels.
Conclusions
We have shown here that transcription of pfhrp2 and pfhrp3 and
expression of PfHRP protein levels varies between laboratory
strains of the parasite, and demonstrated that the variation in
protein levels results in differences in RDT detection thresholds.
The outcome of this study provides a possible explanation for
reported variation in sensitivity of PfHRP2-detecting RDTs and
will assist research aimed at improving malaria RDTs.
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